Mechanism of Action
The pharmacodynamics of Tramadol is unique and includes two components:
- Opioid component: acts as a central non-selective agonist of $\mu$-, $\delta$-, and $\kappa$-opioid receptors.
- Non-opioid (monoaminergic) component: inhibits the neuronal uptake of norepinephrine and serotonin, which enhances descending inhibitory pathways on pain impulse transmission in the spinal cord.
Pharmacological Effects
The drug exhibits pronounced analgesic activity, although it is less potent than morphine. A key advantage over classic opioids is its improved safety profile: Tramadol practically does not depress the respiratory center, does not reduce gastrointestinal motility (lower risk of constipation), and does not increase urinary tract tone.
Indications
Used for pain relief of various etiologies:
- Postoperative pain.
- Cancer pain.
- Pain associated with myocardial infarction.
- Traumatic injuries.
Administration and Dosage
The drug is available in a wide range of dosage forms: capsules (0.05 g), tablets (0.05 and 0.1 g), drops (0.1 g), 5% ampoules (1 and 2 ml), and suppositories (0.1 g).
Dosing Regimen:
- Oral: 0.05–0.1 g (Maximal Daily Dose [MDD]: 0.4 g).
- Parenteral (IV, IM, SC): 0.05–0.1 g (MDD: 0.4 g).
- Rectal: 0.1 g (MDD: 0.4 g).